
    
      A Phase I, Open-Label, Multicentre Study to Assess the Safety, Tolerability, Pharmacokinetics
      and Preliminary Anti-tumour Activity of Ascending Doses of AZD1208 in Patients with Advanced
      Solid Malignancies including Malignant Lymphoma
    
  